Avalo Therapeutics Inc.
AVTX | NASDAQ
$16.17
-$0.40 (-2.41%)
At close: Sep 21, 2026, 4:00 PM ET
$16.18
+$0.01 (+0.06%)
Pre-market:
Sep 22, 2026, 8:25 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 59K | 59K | 59K | 192K | 441K | 441K | 441K | 820K | 807K | 1.45M | 1.93M | 2.25M | 16.96M | 17.35M | 18.05M | 17.37M | 3.78M | 6.1M | 5.4M | 6.68M | 6.44M | 4.42M |
Cost of Revenue | 10.01M | 20.67M | 26.56M | 26.65M | 15.95M | 5.63M | -364K | -672K | 282K | 647K | 5.71M | 6.55M | 6.84M | 7.7M | 3.44M | 11.58M | 11.96M | 20.35M | 19.7M | 21.55M | 20.72M | 10.84M |
Gross Profit | -9.95M | -20.61M | -26.5M | -26.46M | -15.5M | -5.19M | 805K | 1.49M | 525K | 803K | -3.79M | -4.3M | 10.12M | 9.66M | 14.62M | 5.8M | -8.18M | -14.25M | -14.31M | -14.88M | -14.29M | -6.42M |
Operating Income | -91.36M | -79.16M | -72.93M | -66.49M | -60.16M | -50.42M | -68.51M | -58.95M | -49.84M | -47.42M | -23.44M | -28.55M | -20.7M | -25.38M | -37.44M | -46.55M | -67.11M | -81.86M | -91.58M | -146.46M | -143.28M | -128.51M |
Interest Income | 5.67M | 4.01M | 4.36M | 4.58M | 4.43M | 4.37M | 3.32M | 2.18M | 1.22M | 181K | 81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K | 17K | 17K | 25.71K |
Pretax Income | -100.16M | -84.57M | -78.09M | -99.73M | -46.09M | 73.13M | -35.02M | -7.97M | -36.21M | -142.87M | -31.53M | -33.16M | -24.74M | -29.54M | -41.63M | -50.94M | -71.6M | -75.6M | -84.12M | -81.33M | -77.12M | -73.43M |
Net Income | -100.33M | -84.74M | -78.26M | -99.88M | -46.22M | 73.01M | -35.13M | -7.96M | -36.22M | -142.88M | -31.54M | -33.19M | -24.77M | -29.56M | -41.66M | -51.04M | -71.63M | -75.75M | -84.38M | -80.82M | -76.89M | -73.06M |
Selling & General & Admin | 27.05M | 24.19M | 22.9M | 21.6M | 20.31M | 19.59M | 17.24M | 14.68M | 12.89M | 10.79M | 10.3M | 10.58M | 11.38M | 11.74M | 20.71M | 23.73M | 26.38M | 31M | 24.66M | 23.75M | 22.86M | 22.21M |
Research & Development | 64.35M | 55.01M | 50.09M | 45M | 40.92M | 31.55M | 52.08M | 45.76M | 37.47M | 37.43M | 13.78M | 18.09M | 23.88M | 27.73M | 31.31M | 36.65M | 40.16M | 44.21M | 59.84M | 60.96M | 59.28M | 52.63M |
Other Expenses | -9.99M | -20.65M | -26.56M | -26.56M | -16.57M | -5.91M | n/a | n/a | 7K | 7K | -4.43M | -4.43M | -4.43M | -4.43M | 38K | -8.03M | -7.6M | -7.6M | -7.22M | 46.87M | 46.85M | 47.25M |
Operating Expenses | 81.41M | 58.55M | 46.42M | 40.04M | 44.65M | 45.23M | 69.32M | 60.45M | 50.37M | 48.22M | 19.66M | 24.25M | 30.83M | 35.04M | 52.06M | 52.35M | 58.93M | 67.61M | 77.28M | 131.58M | 128.99M | 122.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.55M | 2.55M | 3.5M | 4.45M | 3.79M | 3.95M | 4.17M | 4.41M | 4.49M | 3.58M | 2.41M | 1.22M | 239K | n/a |
Selling & Marketing Expenses | 403K | 459K | 471K | 879K | 999K | 964K | 959K | 177K | 35K | 21K | 27K | 32K | 38K | 45K | 1.96M | 3.61M | 4.08M | 4.5M | 3.01M | 1.9M | 1.88M | 2.1M |
Cost & Expenses | 91.42M | 79.22M | 72.98M | 66.69M | 60.6M | 50.86M | 68.96M | 59.77M | 50.65M | 48.87M | 25.37M | 30.8M | 37.67M | 42.73M | 55.49M | 63.92M | 70.88M | 87.95M | 96.98M | 153.14M | 149.71M | 132.93M |
Income Tax Expense | 171K | 169K | 165K | 149K | 124K | 115K | 114K | -9K | 13K | 13K | 14K | 31K | 28K | 26K | 27K | 35K | 38K | 232K | 234K | 32K | 27K | -626K |
Shares Outstanding (Basic) | 43.6M | 20.11M | 18.51M | 14M | 10.83M | 10.51M | 10.47M | 5.55M | 1.03M | 859.38K | 801.75K | 194.85K | 58.22K | 48.85K | 39.25K | 39.22K | 39.17K | 39.17K | 39.63K | 34.89K | 37.71K | 32.94K |
Shares Outstanding (Diluted) | 43.6M | 20.11M | 18.51M | 14M | 10.83M | 10.51M | 10.47M | 10.78M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.85K | 39.25K | 39.22K | 39.17K | 39.17K | 39.63K | 34.89K | 37.71K | 32.94K |
EPS (Basic) | -4.74 | -5.83 | -6.10 | 8.53 | 13.55 | 110.68 | -29.21 | -53.29 | -82.95 | -318.89 | -381.56 | -621.36 | -513.15 | -703.97 | -1.06K | -1.3K | -1.88K | -2K | -2.37K | -2.44K | -2.42K | -2.52K |
EPS (Diluted) | -4.74 | -5.83 | -6.10 | 5.11 | 9.44 | 24.23 | -115.66 | -136.32 | -165.29 | -318.89 | -381.56 | -621.36 | -513.15 | -703.97 | -1.06K | -1.3K | -1.88K | -2K | -2.37K | -2.44K | -2.42K | -2.52K |
EBITDA | -100.04M | -84.35M | -77.75M | -99.33M | -45.72M | 73.4M | -34.85M | -7.9M | -34.59M | -140.24M | -27.96M | -28.56M | -20.81M | -25.45M | -37.3M | -46.11M | -66.26M | -71.14M | -80.46M | -79.43M | -76.23M | -70.95M |
EBIT | -100.16M | -84.57M | -78.09M | -99.73M | -46.09M | 73.13M | -35.02M | -8.05M | -34.74M | -140.4M | -28.11M | -28.71M | -20.95M | -25.59M | -37.46M | -46.54M | -67.11M | -72.41M | -82.12M | -81.33M | -78.11M | -72.79M |
Depreciation & Amortization | 126K | 226K | 344K | 396K | 371K | 270K | 169K | 144K | 151K | 159K | 158K | 150K | 143K | 132K | 166K | 426K | 847K | 1.27M | 1.66M | 1.9M | 1.87M | 1.84M |
Add to Watchlist
Select watchlists to add or remove AVTX